Johnson & Johnson Launches ETHICON™ 4000 Advanced Laparoscopic Stapler, Reducing Anastomotic Bleeding by 23%

Johnson & Johnson announces its advancedETHICON 4000CavityMirrorStapler Receives FDA Approval for Market Launch.ETHICON 4000Designed to address complex tissue environments, providing superior suture line integrity to reduce the risk factors of leakage and bleeding complications across various surgical specialties.

Expert Evaluation

"The 3D stapling technology allows me to distribute pressure more evenly and consistently across the entire staple line. As a surgeon, these technological advancements in the ETHICON 4000 give me greater peace of mind when dealing with complex tissues, even during the most intricate procedures. As the Chief Medical Quality Officer, we must evaluate all devices from the perspectives of safety and value, which is crucial for our institution."

---Kelvin D. Higa  Fresno Heart and Surgical Hospital

Executive Evaluation

"We are introducing new solutions aimed at addressing some of the most common and costly surgical complications, building on our legacy of innovation and reliable performance in the field of surgical instruments. As surgeons strive to meet the evolving needs of patients, surgical techniques must also advance with the times. Through continuous innovation, Johnson & Johnson provides a consistently reliable surgical experience for open surgery, minimally invasive surgery, and robotic surgery."

---Hani Abouhalka  Chairman of the Johnson & Johnson Medical Technology Surgical Division

Nowadays, staplers have become indispensable in surgical operations. However, when traditional staplers are used to anastomose tissues, the complex variables caused by uneven, fragile, and inconsistent tissues may damage the integrity of the staple line, leading to leakage or bleeding. Only in the United States, the cost burden brought by complications in key surgeries is estimated to be close to 30 billion US dollars. About half of bariatric surgeons report that they take extra steps to reduce leakage and bleeding complications at the staple line, including using auxiliary hemostatic products, placing clips, or performing reinforcement sutures.

Johnson & Johnson's Newly Launched StaplerETHICON 4000 is designed to address anastomotic issues.Leakage or bleeding issues. WhenETHICON 4000 CooperationWhen using ETHICON 3D stapler cartridges, the performance of the stapler is significantly enhanced, thereby reducing common complications associated with staplers. Compared to traditional staplers, it can reduce anastomotic bleeding by 23%.

ETHICON 4000

ETHICON 4000It is Johnson & Johnson's most advanced endoscopic stapler, specifically designed to handle complex tissues, providing excellent staple line integrity and aiming to reduce anastomotic leakage and bleeding complications during surgical procedures.

ETHICON 4000Equipped with Johnson & Johnson's most advanced cartridge technology---ETHICON 3D Staple Cartridge, utilizing Johnson & Johnson's proprietary 3D stapling technology and enhanced Gripping Surface Technology (GST) to handle complex tissues, reducing the potential risk of staple line leakage and bleeding.

ETHICON 4000 Technical Core

• Patented 3D staples with staggered leg design

• Reinforced Reconstructed End Effector

• Simplified cartridge options ensure ultimate consistency of the first and last staple.

Johnson & Johnson has always been committed to addressing the most complex health challenges globally. For over a century, we have advanced surgical care through innovative products such as wound closure, hemostatic assistance, surgical stapling devices, robotics, and digital solutions. Collaborating with clinical experts worldwide, we continuously revolutionize surgical techniques to better meet patient needs in metabolic diseases, cardiovascular diseases, oncology, and reconstructive surgery.